Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain

Abstract Cognitive decline is a common pathological outcome during aging, with an ill‐defined molecular and cellular basis. In recent years, the concept of inflammaging, defined as a low‐grade inflammation increasing with age, has emerged. Infiltrating T cells accumulate in the brain with age and ma...

Full description

Bibliographic Details
Main Authors: Pierre Lemaitre, Samar HK Tareen, Emanuela Pasciuto, Loriana Mascali, Araks Martirosyan, Zsuzsanna Callaerts‐Vegh, Suresh Poovathingal, James Dooley, Matthew G Holt, Lidia Yshii, Adrian Liston
Format: Article
Language:English
Published: Springer Nature 2023-05-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.202216805
_version_ 1797279754418651136
author Pierre Lemaitre
Samar HK Tareen
Emanuela Pasciuto
Loriana Mascali
Araks Martirosyan
Zsuzsanna Callaerts‐Vegh
Suresh Poovathingal
James Dooley
Matthew G Holt
Lidia Yshii
Adrian Liston
author_facet Pierre Lemaitre
Samar HK Tareen
Emanuela Pasciuto
Loriana Mascali
Araks Martirosyan
Zsuzsanna Callaerts‐Vegh
Suresh Poovathingal
James Dooley
Matthew G Holt
Lidia Yshii
Adrian Liston
author_sort Pierre Lemaitre
collection DOAJ
description Abstract Cognitive decline is a common pathological outcome during aging, with an ill‐defined molecular and cellular basis. In recent years, the concept of inflammaging, defined as a low‐grade inflammation increasing with age, has emerged. Infiltrating T cells accumulate in the brain with age and may contribute to the amplification of inflammatory cascades and disruptions to the neurogenic niche observed with age. Recently, a small resident population of regulatory T cells has been identified in the brain, and the capacity of IL2‐mediated expansion of this population to counter neuroinflammatory disease has been demonstrated. Here, we test a brain‐specific IL2 delivery system for the prevention of neurological decline in aging mice. We identify the molecular hallmarks of aging in the brain glial compartments and identify partial restoration of this signature through IL2 treatment. At a behavioral level, brain IL2 delivery prevented the age‐induced defect in spatial learning, without improving the general decline in motor skill or arousal. These results identify immune modulation as a potential path to preserving cognitive function for healthy aging.
first_indexed 2024-03-07T16:30:33Z
format Article
id doaj.art-78934a3a099a43c781c47882cc383255
institution Directory Open Access Journal
issn 1757-4676
1757-4684
language English
last_indexed 2024-03-07T16:30:33Z
publishDate 2023-05-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj.art-78934a3a099a43c781c47882cc3832552024-03-03T10:44:15ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842023-05-01155n/an/a10.15252/emmm.202216805Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brainPierre Lemaitre0Samar HK Tareen1Emanuela Pasciuto2Loriana Mascali3Araks Martirosyan4Zsuzsanna Callaerts‐Vegh5Suresh Poovathingal6James Dooley7Matthew G Holt8Lidia Yshii9Adrian Liston10VIB Center for Brain and Disease Research Leuven BelgiumImmunology Programme The Babraham Institute Babraham UKVIB Center for Brain and Disease Research Leuven BelgiumVIB Center for Brain and Disease Research Leuven BelgiumVIB Center for Brain and Disease Research Leuven BelgiumLaboratory of Biological Psychology, Faculty of Psychology KU Leuven Leuven BelgiumVIB Center for Brain and Disease Research Leuven BelgiumImmunology Programme The Babraham Institute Babraham UKVIB Center for Brain and Disease Research Leuven BelgiumVIB Center for Brain and Disease Research Leuven BelgiumVIB Center for Brain and Disease Research Leuven BelgiumAbstract Cognitive decline is a common pathological outcome during aging, with an ill‐defined molecular and cellular basis. In recent years, the concept of inflammaging, defined as a low‐grade inflammation increasing with age, has emerged. Infiltrating T cells accumulate in the brain with age and may contribute to the amplification of inflammatory cascades and disruptions to the neurogenic niche observed with age. Recently, a small resident population of regulatory T cells has been identified in the brain, and the capacity of IL2‐mediated expansion of this population to counter neuroinflammatory disease has been demonstrated. Here, we test a brain‐specific IL2 delivery system for the prevention of neurological decline in aging mice. We identify the molecular hallmarks of aging in the brain glial compartments and identify partial restoration of this signature through IL2 treatment. At a behavioral level, brain IL2 delivery prevented the age‐induced defect in spatial learning, without improving the general decline in motor skill or arousal. These results identify immune modulation as a potential path to preserving cognitive function for healthy aging.https://doi.org/10.15252/emmm.202216805AgingBrainGene TherapyInterleukin 2Regulatory T cells
spellingShingle Pierre Lemaitre
Samar HK Tareen
Emanuela Pasciuto
Loriana Mascali
Araks Martirosyan
Zsuzsanna Callaerts‐Vegh
Suresh Poovathingal
James Dooley
Matthew G Holt
Lidia Yshii
Adrian Liston
Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain
EMBO Molecular Medicine
Aging
Brain
Gene Therapy
Interleukin 2
Regulatory T cells
title Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain
title_full Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain
title_fullStr Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain
title_full_unstemmed Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain
title_short Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain
title_sort molecular and cognitive signatures of ageing partially restored through synthetic delivery of il2 to the brain
topic Aging
Brain
Gene Therapy
Interleukin 2
Regulatory T cells
url https://doi.org/10.15252/emmm.202216805
work_keys_str_mv AT pierrelemaitre molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT samarhktareen molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT emanuelapasciuto molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT lorianamascali molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT araksmartirosyan molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT zsuzsannacallaertsvegh molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT sureshpoovathingal molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT jamesdooley molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT matthewgholt molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT lidiayshii molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain
AT adrianliston molecularandcognitivesignaturesofageingpartiallyrestoredthroughsyntheticdeliveryofil2tothebrain